These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 9234802)

  • 21. Purification and characterization of Borrelia burgdorferi from feeding nymphal ticks (Ixodes scapularis).
    Rathinavelu S; de Silva AM
    Infect Immun; 2001 Jun; 69(6):3536-41. PubMed ID: 11349010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct patterns of protective antibodies are generated against Borrelia burgdorferi in mice experimentally inoculated with high and low doses of antigen.
    Schaible UE; Gern L; Wallich R; Kramer MD; Prester M; Simon MM
    Immunol Lett; 1993 May; 36(2):219-26. PubMed ID: 8349316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice.
    Fikrig E; Telford SR; Barthold SW; Kantor FS; Spielman A; Flavell RA
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5418-21. PubMed ID: 1608951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective immunization with plasmid DNA containing the outer surface lipoprotein A gene of Borrelia burgdorferi is independent of an eukaryotic promoter.
    Simon MM; Gern L; Hauser P; Zhong W; Nielsen PJ; Kramer MD; Brenner C; Wallich R
    Eur J Immunol; 1996 Dec; 26(12):2831-40. PubMed ID: 8977275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination of natural reservoir hosts with recombinant lipidated OspA induces a transmission-blocking immunity against Lyme disease spirochaetes associated with high levels of LA-2 equivalent antibodies.
    Kurtenbach K; Dizij A; Voet P; Hauser P; Simon MM
    Vaccine; 1997 Oct; 15(15):1670-4. PubMed ID: 9364698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccination against lyme disease with recombinant Borrelia burgdorferi outer-surface protein A (rOspA) in horses.
    Chang Y; Novosol V; McDonough SP; Chang CF; Jacobson RH; Divers T; Quimby FW; Shin S; Lein DH
    Vaccine; 1999 Oct; 18(5-6):540-8. PubMed ID: 10519945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production of outer surface protein A by Borrelia burgdorferi during transmission from infected mammals to feeding ticks is insufficient to trigger OspA seroconversion.
    Woodman ME; Cooley AE; Stevenson B
    FEMS Immunol Med Microbiol; 2008 Nov; 54(2):277-82. PubMed ID: 18793197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective efficacy of an oral vaccine to reduce carriage of Borrelia burgdorferi (strain N40) in mouse and tick reservoirs.
    Scheckelhoff MR; Telford SR; Hu LT
    Vaccine; 2006 Mar; 24(11):1949-57. PubMed ID: 16300863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of a nonadjuvanted, outer surface protein A, recombinant vaccine in dogs after challenge by ticks naturally infected with Borrelia burgdorferi.
    Conlon JA; Mather TN; Tanner P; Gallo G; Jacobson RH
    Vet Ther; 2000; 1(2):96-107. PubMed ID: 19757556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant OspA protects dogs against infection and disease caused by Borrelia burgdorferi.
    Chang YF; Appel MJ; Jacobson RH; Shin SJ; Harpending P; Straubinger R; Patrican LA; Mohammed H; Summers BA
    Infect Immun; 1995 Sep; 63(9):3543-9. PubMed ID: 7642289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The hamster immune response to tick-transmitted Borrelia burgdorferi differs from the response to needle-inoculated, cultured organisms.
    Roehrig JT; Piesman J; Hunt AR; Keen MG; Happ CM; Johnson BJ
    J Immunol; 1992 Dec; 149(11):3648-53. PubMed ID: 1431134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specificity of infection-induced immunity among Borrelia burgdorferi sensu lato species.
    Barthold SW
    Infect Immun; 1999 Jan; 67(1):36-42. PubMed ID: 9864193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural antibody affects survival of the spirochete Borrelia burgdorferi within feeding ticks.
    Belperron AA; Bockenstedt LK
    Infect Immun; 2001 Oct; 69(10):6456-62. PubMed ID: 11553590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lyme borreliosis in transgenic mice tolerant to Borrelia burgdorferi OspA or B.
    Fikrig E; Tao H; Chen M; Barthold SW; Flavell RA
    J Clin Invest; 1995 Oct; 96(4):1706-14. PubMed ID: 7560061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attachment of Borrelia burgdorferi within Ixodes scapularis mediated by outer surface protein A.
    Pal U; de Silva AM; Montgomery RR; Fish D; Anguita J; Anderson JF; Lobet Y; Fikrig E
    J Clin Invest; 2000 Aug; 106(4):561-9. PubMed ID: 10953031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Borrelia burgdorferi sensu stricto, Borrelia garinii and Borrelia afzelii in Ixodes ricinus ticks from southern Bohemia using monoclonal antibodies.
    Stĕpánová-Tresová G; Kopecký J; Kuthejlová M
    Zentralbl Bakteriol; 2000 Jan; 289(8):797-806. PubMed ID: 10705611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi.
    Luke CJ; Carner K; Liang X; Barbour AG
    J Infect Dis; 1997 Jan; 175(1):91-7. PubMed ID: 8985201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resolution of experimental and tick-borne Borrelia burgdorferi infection in mice by passive, but not active immunization using recombinant OspC.
    Zhong W; Gern L; Stehle T; Museteanu C; Kramer M; Wallich R; Simon MM
    Eur J Immunol; 1999 Mar; 29(3):946-57. PubMed ID: 10092099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-exposure Prophylaxis With OspA-Specific Human Monoclonal Antibodies Protects Mice Against Tick Transmission of Lyme Disease Spirochetes.
    Wang Y; Kern A; Boatright NK; Schiller ZA; Sadowski A; Ejemel M; Souders CA; Reimann KA; Hu L; Thomas WD; Klempner MS
    J Infect Dis; 2016 Jul; 214(2):205-11. PubMed ID: 27338767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new approach to a Lyme disease vaccine.
    Livey I; O'Rourke M; Traweger A; Savidis-Dacho H; Crowe BA; Barrett PN; Yang X; Dunn JJ; Luft BJ
    Clin Infect Dis; 2011 Feb; 52 Suppl 3():s266-70. PubMed ID: 21217174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.